Stocks making the biggest moves after hours: Beyond Meat, KB Home, Steelcase and more

StreetInsider2021-06-24

Check out the companies making headlines after the bell: DHI Group, Inc. (NYSE:DHX)26.5% HIGHER; authorized a stock repurchase program that permits the additional purchase of up to $12 million of the ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Phyusin
2021-06-24
Phyusin
Perfect
nAonkA
2021-06-24
nAonkA
Nice
Lamborghini1
2021-06-24
Lamborghini1
Yes
JPTL
2021-06-24
JPTL
??
lgperry
2021-06-24
lgperry
Ok
Jtrfed
2021-06-24
Jtrfed
Nice

Leave a comment

223

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1197804089?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2021-06-24 07:33","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1197804089","market":"us","top_or_hot":-1,"title":"Stocks making the biggest moves after hours: Beyond Meat, KB Home, Steelcase and more","media":"StreetInsider","content":"<div>\n<p>Check out the companies making headlines after the bell:\nDHI Group, Inc. (NYSE:DHX)26.5% HIGHER; authorized a stock repurchase program that permits the additional purchase of up to $12 million of the ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18597276\">Source Link</a>\n\n</div>\n","source":"highlight_streetinsider","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stocks making the biggest moves after hours: Beyond Meat, KB Home, Steelcase and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStocks making the biggest moves after hours: Beyond Meat, KB Home, Steelcase and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-24 07:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18597276><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Check out the companies making headlines after the bell:\nDHI Group, Inc. (NYSE:DHX)26.5% HIGHER; authorized a stock repurchase program that permits the additional purchase of up to $12 million of the ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18597276\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PRTG","symbol_name":"Portage Biotech Inc.","start_time":0,"source_url":"https://www.streetinsider.com/dr/news.php?id=18597276","article_id":"1197804089","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1197804089","pubTimestamp":1624491201,"sourceInfo":{"source_id":"highlight_streetinsider","name":"StreetInsider"},"weMediaInfo":null,"summary":"Check out the companies making headlines after the bell:. DHI Group, Inc. 26.5% HIGHER; authorized a stock repurchase program that permits the additional purchase of up to $12 million of the Company's common stock, increasing the overall share buyback program to $20 million. In February 2021, the Board of Directors authorized the purchase of $8 million of its common stock and, under the plan, the Company has purchased approximately $1.3 million of its stock to date. With this additional authoriz","collect":0,"end_time":0,"defaultTopTitle":"streetinsider.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"PRTG":"Portage Biotech Inc.","BYND":"Beyond Meat, Inc.","KBH":"KB Home","SCS":"Steelcase Inc.","DHX":"戴斯控股","CXM":"Sprinklr, Inc."},"translate_title":"盘后涨幅最大的个股有：Beyond Meat、KB Home、Steelcase等","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BYND":0.9,"CXM":0.9,"DHX":0.9,"KBH":0.9,"PRTG":0.9,"SCS":0.9},"content_text":"Check out the companies making headlines after the bell:\nDHI Group, Inc. (NYSE:DHX)26.5% HIGHER; authorized a stock repurchase program that permits the additional purchase of up to $12 million of the Company's common stock, increasing the overall share buyback program to $20 million. In February 2021, the Board of Directors authorized the purchase of $8 million of its common stock and, under the plan, the Company has purchased approximately $1.3 million of its stock to date. With this additional authorization, the Company now has $18.7 million of buyback capacity.\nPortage Biotech Inc. (NASDAQ:PRTG)23.3% LOWER; commenced an underwritten public offering of its ordinary shares. In addition, Portage expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of the ordinary shares sold in connection with the offering. All of the ordinary shares in the offering are to be sold by Portage. This offering is subject to market conditions and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.\nArcus Biosciences, Inc. (NYSE:RCUS)19% HIGHER; announced that, at the first interim analysis of the three-arm randomized Phase 2 ARC-7 study, both arms with domvanalimab-based combinations showed encouraging clinical activity (measured by overall response rate; ORR) when given as an initial treatment (first-line) to people with metastatic, PD-L150% non-small cell lung cancer (NSCLC). The zimberelimab monotherapy arm showed activity similar to that of marketed anti-PD-1 antibodies studied by other companies in this setting. At the time of data cut off, no unexpected safety signals were observed; and the current safety profile for each arm of the study appears to be consistent with known immune checkpoint inhibitors in this setting. All three arms of the ARC-7 trial, and the ongoing ARC-10 Phase 3 registrational study, will continue to enroll as planned; and ARC-7 data will be submitted later this year for presentation at a medical conference.\nSprinklr (NYSE:CXM)9% HIGHER; shares are up following its NYSE debut Wednesday when it rose 10% after a weak start.\nTalos Energy Inc. (NYSE:TALO)6.2% LOWER; announced today an underwritten public offering of an aggregate of 5,000,000 shares of its common stock (the \"Offering\") by certain affiliates of Apollo Global Management and Riverstone Holdings LLC (the \"Selling Stockholders\"). Talos is not selling any shares of common stock in the Offering and will not receive any proceeds from any sale of shares by the Selling Stockholders.\nSteelcase (NYSE:SCS)5.2% HIGHER; reported Q1 EPS of ($0.24), $0.07 better than the analyst estimate of ($0.31). Revenue for the quarter came in at $566.6 million versus the consensus estimate of $554.8 million. Steelcase sees Q2 2021 EPS of $0.25-$0.30, versus the consensus of $0.22. Steelcase sees Q2 2021 revenue of $750-780 million, versus the consensus of $704 million.\nLightening eMotors (NYSE:ZEV)4.2% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $15.00.\nKB Home (NYSE:KBH)3.8% LOWER; reported Q2 EPS of $1.50, $0.19 better than the analyst estimate of $1.31. Revenue for the quarter came in at $1.44 billion versus the consensus estimate of $1.5 billion.\nIntrepid Potash (NYSE:IPI)3.2% HIGHER; Increases Potash Price by $90; Trio® Price by $35\nBroadstone Net Lease, Inc. (NYSE:BNL)2.6% LOWER; announced that it has commenced an underwritten public offering of 10,000,000 shares of its common stock\nBeyond Meat Inc. (NASDAQ:BYND)1.5% LOWER; JPMorgan analyst Ken Goldman reiterated an Underweight rating on Beyond Meat Inc. (NASDAQ:BYND), saying based on their checks Dunkin’ recently discontinued the Beyond Sausage breakfast sandwich.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":126046190,"gmtCreate":1624539789310,"gmtModify":1703839744619,"author":{"id":"3584490239949882","authorId":"3584490239949882","name":"Phyusin","avatar":"https://static.tigerbbs.com/73d7e61a3a910d1d25acb7dcee29f7ca","vip":1,"crmLevel":4,"crmLevelSwitch":0,"authorIdStr":"3584490239949882","idStr":"3584490239949882"},"htmlText":"Perfect&nbsp;","listText":"Perfect&nbsp;","text":"Perfect","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/126046190","repostId":1197804089,"repostType":4,"repost":{"id":"1197804089","pubTimestamp":1624491201,"share":"https://ttm.financial/m/news/1197804089?lang=&edition=fundamental","pubTime":"2021-06-24 07:33","market":"us","language":"en","title":"Stocks making the biggest moves after hours: Beyond Meat, KB Home, Steelcase and more","url":"https://stock-news.laohu8.com/highlight/detail?id=1197804089","media":"StreetInsider","summary":"Check out the companies making headlines after the bell:. DHI Group, Inc. 26.5% HIGHER; authorized a stock repurchase program that permits the additional purchase of up to $12 million of the Company's common stock, increasing the overall share buyback program to $20 million. In February 2021, the Board of Directors authorized the purchase of $8 million of its common stock and, under the plan, the Company has purchased approximately $1.3 million of its stock to date. With this additional authoriz","content":"<p><i>Check out the companies making headlines after the bell</i>:</p>\n<p>DHI Group, Inc. (NYSE:DHX)26.5% HIGHER; authorized a stock repurchase program that permits the additional purchase of up to $12 million of the Company's common stock, increasing the overall share buyback program to $20 million. In February 2021, the Board of Directors authorized the purchase of $8 million of its common stock and, under the plan, the Company has purchased approximately $1.3 million of its stock to date. With this additional authorization, the Company now has $18.7 million of buyback capacity.</p>\n<p>Portage Biotech Inc. (NASDAQ:PRTG)23.3% LOWER; commenced an underwritten public offering of its ordinary shares. In addition, Portage expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of the ordinary shares sold in connection with the offering. All of the ordinary shares in the offering are to be sold by Portage. This offering is subject to market conditions and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.</p>\n<p>Arcus Biosciences, Inc. (NYSE:RCUS)19% HIGHER; announced that, at the first interim analysis of the three-arm randomized Phase 2 ARC-7 study, both arms with domvanalimab-based combinations showed encouraging clinical activity (measured by overall response rate; ORR) when given as an initial treatment (first-line) to people with metastatic, PD-L150% non-small cell lung cancer (NSCLC). The zimberelimab monotherapy arm showed activity similar to that of marketed anti-PD-1 antibodies studied by other companies in this setting. At the time of data cut off, no unexpected safety signals were observed; and the current safety profile for each arm of the study appears to be consistent with known immune checkpoint inhibitors in this setting. All three arms of the ARC-7 trial, and the ongoing ARC-10 Phase 3 registrational study, will continue to enroll as planned; and ARC-7 data will be submitted later this year for presentation at a medical conference.</p>\n<p>Sprinklr (NYSE:CXM)9% HIGHER; shares are up following its NYSE debut Wednesday when it rose 10% after a weak start.</p>\n<p>Talos Energy Inc. (NYSE:TALO)6.2% LOWER; announced today an underwritten public offering of an aggregate of 5,000,000 shares of its common stock (the \"Offering\") by certain affiliates of Apollo Global Management and Riverstone Holdings LLC (the \"Selling Stockholders\"). Talos is not selling any shares of common stock in the Offering and will not receive any proceeds from any sale of shares by the Selling Stockholders.</p>\n<p>Steelcase (NYSE:SCS)5.2% HIGHER; reported Q1 EPS of ($0.24), $0.07 better than the analyst estimate of ($0.31). Revenue for the quarter came in at $566.6 million versus the consensus estimate of $554.8 million. Steelcase sees Q2 2021 EPS of $0.25-$0.30, versus the consensus of $0.22. Steelcase sees Q2 2021 revenue of $750-780 million, versus the consensus of $704 million.</p>\n<p>Lightening eMotors (NYSE:ZEV)4.2% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $15.00.</p>\n<p>KB Home (NYSE:KBH)3.8% LOWER; reported Q2 EPS of $1.50, $0.19 better than the analyst estimate of $1.31. Revenue for the quarter came in at $1.44 billion versus the consensus estimate of $1.5 billion.</p>\n<p>Intrepid Potash (NYSE:IPI)3.2% HIGHER; Increases Potash Price by $90; Trio® Price by $35</p>\n<p>Broadstone Net Lease, Inc. (NYSE:BNL)2.6% LOWER; announced that it has commenced an underwritten public offering of 10,000,000 shares of its common stock</p>\n<p>Beyond Meat Inc. (NASDAQ:BYND)1.5% LOWER; JPMorgan analyst Ken Goldman reiterated an Underweight rating on Beyond Meat Inc. (NASDAQ:BYND), saying based on their checks Dunkin’ recently discontinued the Beyond Sausage breakfast sandwich.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stocks making the biggest moves after hours: Beyond Meat, KB Home, Steelcase and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStocks making the biggest moves after hours: Beyond Meat, KB Home, Steelcase and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-24 07:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18597276><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Check out the companies making headlines after the bell:\nDHI Group, Inc. (NYSE:DHX)26.5% HIGHER; authorized a stock repurchase program that permits the additional purchase of up to $12 million of the ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18597276\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PRTG":"Portage Biotech Inc.","KBH":"KB Home","SCS":"Steelcase Inc.","BYND":"Beyond Meat, Inc.","CXM":"Sprinklr, Inc.","DHX":"戴斯控股"},"source_url":"https://www.streetinsider.com/dr/news.php?id=18597276","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1197804089","content_text":"Check out the companies making headlines after the bell:\nDHI Group, Inc. (NYSE:DHX)26.5% HIGHER; authorized a stock repurchase program that permits the additional purchase of up to $12 million of the Company's common stock, increasing the overall share buyback program to $20 million. In February 2021, the Board of Directors authorized the purchase of $8 million of its common stock and, under the plan, the Company has purchased approximately $1.3 million of its stock to date. With this additional authorization, the Company now has $18.7 million of buyback capacity.\nPortage Biotech Inc. (NASDAQ:PRTG)23.3% LOWER; commenced an underwritten public offering of its ordinary shares. In addition, Portage expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of the ordinary shares sold in connection with the offering. All of the ordinary shares in the offering are to be sold by Portage. This offering is subject to market conditions and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.\nArcus Biosciences, Inc. (NYSE:RCUS)19% HIGHER; announced that, at the first interim analysis of the three-arm randomized Phase 2 ARC-7 study, both arms with domvanalimab-based combinations showed encouraging clinical activity (measured by overall response rate; ORR) when given as an initial treatment (first-line) to people with metastatic, PD-L150% non-small cell lung cancer (NSCLC). The zimberelimab monotherapy arm showed activity similar to that of marketed anti-PD-1 antibodies studied by other companies in this setting. At the time of data cut off, no unexpected safety signals were observed; and the current safety profile for each arm of the study appears to be consistent with known immune checkpoint inhibitors in this setting. All three arms of the ARC-7 trial, and the ongoing ARC-10 Phase 3 registrational study, will continue to enroll as planned; and ARC-7 data will be submitted later this year for presentation at a medical conference.\nSprinklr (NYSE:CXM)9% HIGHER; shares are up following its NYSE debut Wednesday when it rose 10% after a weak start.\nTalos Energy Inc. (NYSE:TALO)6.2% LOWER; announced today an underwritten public offering of an aggregate of 5,000,000 shares of its common stock (the \"Offering\") by certain affiliates of Apollo Global Management and Riverstone Holdings LLC (the \"Selling Stockholders\"). Talos is not selling any shares of common stock in the Offering and will not receive any proceeds from any sale of shares by the Selling Stockholders.\nSteelcase (NYSE:SCS)5.2% HIGHER; reported Q1 EPS of ($0.24), $0.07 better than the analyst estimate of ($0.31). Revenue for the quarter came in at $566.6 million versus the consensus estimate of $554.8 million. Steelcase sees Q2 2021 EPS of $0.25-$0.30, versus the consensus of $0.22. Steelcase sees Q2 2021 revenue of $750-780 million, versus the consensus of $704 million.\nLightening eMotors (NYSE:ZEV)4.2% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $15.00.\nKB Home (NYSE:KBH)3.8% LOWER; reported Q2 EPS of $1.50, $0.19 better than the analyst estimate of $1.31. Revenue for the quarter came in at $1.44 billion versus the consensus estimate of $1.5 billion.\nIntrepid Potash (NYSE:IPI)3.2% HIGHER; Increases Potash Price by $90; Trio® Price by $35\nBroadstone Net Lease, Inc. (NYSE:BNL)2.6% LOWER; announced that it has commenced an underwritten public offering of 10,000,000 shares of its common stock\nBeyond Meat Inc. (NASDAQ:BYND)1.5% LOWER; JPMorgan analyst Ken Goldman reiterated an Underweight rating on Beyond Meat Inc. (NASDAQ:BYND), saying based on their checks Dunkin’ recently discontinued the Beyond Sausage breakfast sandwich.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":128436243,"gmtCreate":1624526857482,"gmtModify":1703839372914,"author":{"id":"3567471451546980","authorId":"3567471451546980","name":"nAonkA","avatar":"https://static.tigerbbs.com/2c5905f2cf61636f82bdd3d58203997c","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3567471451546980","idStr":"3567471451546980"},"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/128436243","repostId":1197804089,"repostType":4,"repost":{"id":"1197804089","pubTimestamp":1624491201,"share":"https://ttm.financial/m/news/1197804089?lang=&edition=fundamental","pubTime":"2021-06-24 07:33","market":"us","language":"en","title":"Stocks making the biggest moves after hours: Beyond Meat, KB Home, Steelcase and more","url":"https://stock-news.laohu8.com/highlight/detail?id=1197804089","media":"StreetInsider","summary":"Check out the companies making headlines after the bell:. DHI Group, Inc. 26.5% HIGHER; authorized a stock repurchase program that permits the additional purchase of up to $12 million of the Company's common stock, increasing the overall share buyback program to $20 million. In February 2021, the Board of Directors authorized the purchase of $8 million of its common stock and, under the plan, the Company has purchased approximately $1.3 million of its stock to date. With this additional authoriz","content":"<p><i>Check out the companies making headlines after the bell</i>:</p>\n<p>DHI Group, Inc. (NYSE:DHX)26.5% HIGHER; authorized a stock repurchase program that permits the additional purchase of up to $12 million of the Company's common stock, increasing the overall share buyback program to $20 million. In February 2021, the Board of Directors authorized the purchase of $8 million of its common stock and, under the plan, the Company has purchased approximately $1.3 million of its stock to date. With this additional authorization, the Company now has $18.7 million of buyback capacity.</p>\n<p>Portage Biotech Inc. (NASDAQ:PRTG)23.3% LOWER; commenced an underwritten public offering of its ordinary shares. In addition, Portage expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of the ordinary shares sold in connection with the offering. All of the ordinary shares in the offering are to be sold by Portage. This offering is subject to market conditions and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.</p>\n<p>Arcus Biosciences, Inc. (NYSE:RCUS)19% HIGHER; announced that, at the first interim analysis of the three-arm randomized Phase 2 ARC-7 study, both arms with domvanalimab-based combinations showed encouraging clinical activity (measured by overall response rate; ORR) when given as an initial treatment (first-line) to people with metastatic, PD-L150% non-small cell lung cancer (NSCLC). The zimberelimab monotherapy arm showed activity similar to that of marketed anti-PD-1 antibodies studied by other companies in this setting. At the time of data cut off, no unexpected safety signals were observed; and the current safety profile for each arm of the study appears to be consistent with known immune checkpoint inhibitors in this setting. All three arms of the ARC-7 trial, and the ongoing ARC-10 Phase 3 registrational study, will continue to enroll as planned; and ARC-7 data will be submitted later this year for presentation at a medical conference.</p>\n<p>Sprinklr (NYSE:CXM)9% HIGHER; shares are up following its NYSE debut Wednesday when it rose 10% after a weak start.</p>\n<p>Talos Energy Inc. (NYSE:TALO)6.2% LOWER; announced today an underwritten public offering of an aggregate of 5,000,000 shares of its common stock (the \"Offering\") by certain affiliates of Apollo Global Management and Riverstone Holdings LLC (the \"Selling Stockholders\"). Talos is not selling any shares of common stock in the Offering and will not receive any proceeds from any sale of shares by the Selling Stockholders.</p>\n<p>Steelcase (NYSE:SCS)5.2% HIGHER; reported Q1 EPS of ($0.24), $0.07 better than the analyst estimate of ($0.31). Revenue for the quarter came in at $566.6 million versus the consensus estimate of $554.8 million. Steelcase sees Q2 2021 EPS of $0.25-$0.30, versus the consensus of $0.22. Steelcase sees Q2 2021 revenue of $750-780 million, versus the consensus of $704 million.</p>\n<p>Lightening eMotors (NYSE:ZEV)4.2% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $15.00.</p>\n<p>KB Home (NYSE:KBH)3.8% LOWER; reported Q2 EPS of $1.50, $0.19 better than the analyst estimate of $1.31. Revenue for the quarter came in at $1.44 billion versus the consensus estimate of $1.5 billion.</p>\n<p>Intrepid Potash (NYSE:IPI)3.2% HIGHER; Increases Potash Price by $90; Trio® Price by $35</p>\n<p>Broadstone Net Lease, Inc. (NYSE:BNL)2.6% LOWER; announced that it has commenced an underwritten public offering of 10,000,000 shares of its common stock</p>\n<p>Beyond Meat Inc. (NASDAQ:BYND)1.5% LOWER; JPMorgan analyst Ken Goldman reiterated an Underweight rating on Beyond Meat Inc. (NASDAQ:BYND), saying based on their checks Dunkin’ recently discontinued the Beyond Sausage breakfast sandwich.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stocks making the biggest moves after hours: Beyond Meat, KB Home, Steelcase and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStocks making the biggest moves after hours: Beyond Meat, KB Home, Steelcase and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-24 07:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18597276><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Check out the companies making headlines after the bell:\nDHI Group, Inc. (NYSE:DHX)26.5% HIGHER; authorized a stock repurchase program that permits the additional purchase of up to $12 million of the ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18597276\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PRTG":"Portage Biotech Inc.","KBH":"KB Home","SCS":"Steelcase Inc.","BYND":"Beyond Meat, Inc.","CXM":"Sprinklr, Inc.","DHX":"戴斯控股"},"source_url":"https://www.streetinsider.com/dr/news.php?id=18597276","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1197804089","content_text":"Check out the companies making headlines after the bell:\nDHI Group, Inc. (NYSE:DHX)26.5% HIGHER; authorized a stock repurchase program that permits the additional purchase of up to $12 million of the Company's common stock, increasing the overall share buyback program to $20 million. In February 2021, the Board of Directors authorized the purchase of $8 million of its common stock and, under the plan, the Company has purchased approximately $1.3 million of its stock to date. With this additional authorization, the Company now has $18.7 million of buyback capacity.\nPortage Biotech Inc. (NASDAQ:PRTG)23.3% LOWER; commenced an underwritten public offering of its ordinary shares. In addition, Portage expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of the ordinary shares sold in connection with the offering. All of the ordinary shares in the offering are to be sold by Portage. This offering is subject to market conditions and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.\nArcus Biosciences, Inc. (NYSE:RCUS)19% HIGHER; announced that, at the first interim analysis of the three-arm randomized Phase 2 ARC-7 study, both arms with domvanalimab-based combinations showed encouraging clinical activity (measured by overall response rate; ORR) when given as an initial treatment (first-line) to people with metastatic, PD-L150% non-small cell lung cancer (NSCLC). The zimberelimab monotherapy arm showed activity similar to that of marketed anti-PD-1 antibodies studied by other companies in this setting. At the time of data cut off, no unexpected safety signals were observed; and the current safety profile for each arm of the study appears to be consistent with known immune checkpoint inhibitors in this setting. All three arms of the ARC-7 trial, and the ongoing ARC-10 Phase 3 registrational study, will continue to enroll as planned; and ARC-7 data will be submitted later this year for presentation at a medical conference.\nSprinklr (NYSE:CXM)9% HIGHER; shares are up following its NYSE debut Wednesday when it rose 10% after a weak start.\nTalos Energy Inc. (NYSE:TALO)6.2% LOWER; announced today an underwritten public offering of an aggregate of 5,000,000 shares of its common stock (the \"Offering\") by certain affiliates of Apollo Global Management and Riverstone Holdings LLC (the \"Selling Stockholders\"). Talos is not selling any shares of common stock in the Offering and will not receive any proceeds from any sale of shares by the Selling Stockholders.\nSteelcase (NYSE:SCS)5.2% HIGHER; reported Q1 EPS of ($0.24), $0.07 better than the analyst estimate of ($0.31). Revenue for the quarter came in at $566.6 million versus the consensus estimate of $554.8 million. Steelcase sees Q2 2021 EPS of $0.25-$0.30, versus the consensus of $0.22. Steelcase sees Q2 2021 revenue of $750-780 million, versus the consensus of $704 million.\nLightening eMotors (NYSE:ZEV)4.2% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $15.00.\nKB Home (NYSE:KBH)3.8% LOWER; reported Q2 EPS of $1.50, $0.19 better than the analyst estimate of $1.31. Revenue for the quarter came in at $1.44 billion versus the consensus estimate of $1.5 billion.\nIntrepid Potash (NYSE:IPI)3.2% HIGHER; Increases Potash Price by $90; Trio® Price by $35\nBroadstone Net Lease, Inc. (NYSE:BNL)2.6% LOWER; announced that it has commenced an underwritten public offering of 10,000,000 shares of its common stock\nBeyond Meat Inc. (NASDAQ:BYND)1.5% LOWER; JPMorgan analyst Ken Goldman reiterated an Underweight rating on Beyond Meat Inc. (NASDAQ:BYND), saying based on their checks Dunkin’ recently discontinued the Beyond Sausage breakfast sandwich.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":128557339,"gmtCreate":1624525083021,"gmtModify":1703839310376,"author":{"id":"3578903100181699","authorId":"3578903100181699","name":"Lamborghini1","avatar":"https://static.tigerbbs.com/f8b24a649554234324e1e33be42fc25f","vip":1,"crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"3578903100181699","idStr":"3578903100181699"},"htmlText":"Yes","listText":"Yes","text":"Yes","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/128557339","repostId":1197804089,"repostType":4,"repost":{"id":"1197804089","pubTimestamp":1624491201,"share":"https://ttm.financial/m/news/1197804089?lang=&edition=fundamental","pubTime":"2021-06-24 07:33","market":"us","language":"en","title":"Stocks making the biggest moves after hours: Beyond Meat, KB Home, Steelcase and more","url":"https://stock-news.laohu8.com/highlight/detail?id=1197804089","media":"StreetInsider","summary":"Check out the companies making headlines after the bell:. DHI Group, Inc. 26.5% HIGHER; authorized a stock repurchase program that permits the additional purchase of up to $12 million of the Company's common stock, increasing the overall share buyback program to $20 million. In February 2021, the Board of Directors authorized the purchase of $8 million of its common stock and, under the plan, the Company has purchased approximately $1.3 million of its stock to date. With this additional authoriz","content":"<p><i>Check out the companies making headlines after the bell</i>:</p>\n<p>DHI Group, Inc. (NYSE:DHX)26.5% HIGHER; authorized a stock repurchase program that permits the additional purchase of up to $12 million of the Company's common stock, increasing the overall share buyback program to $20 million. In February 2021, the Board of Directors authorized the purchase of $8 million of its common stock and, under the plan, the Company has purchased approximately $1.3 million of its stock to date. With this additional authorization, the Company now has $18.7 million of buyback capacity.</p>\n<p>Portage Biotech Inc. (NASDAQ:PRTG)23.3% LOWER; commenced an underwritten public offering of its ordinary shares. In addition, Portage expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of the ordinary shares sold in connection with the offering. All of the ordinary shares in the offering are to be sold by Portage. This offering is subject to market conditions and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.</p>\n<p>Arcus Biosciences, Inc. (NYSE:RCUS)19% HIGHER; announced that, at the first interim analysis of the three-arm randomized Phase 2 ARC-7 study, both arms with domvanalimab-based combinations showed encouraging clinical activity (measured by overall response rate; ORR) when given as an initial treatment (first-line) to people with metastatic, PD-L150% non-small cell lung cancer (NSCLC). The zimberelimab monotherapy arm showed activity similar to that of marketed anti-PD-1 antibodies studied by other companies in this setting. At the time of data cut off, no unexpected safety signals were observed; and the current safety profile for each arm of the study appears to be consistent with known immune checkpoint inhibitors in this setting. All three arms of the ARC-7 trial, and the ongoing ARC-10 Phase 3 registrational study, will continue to enroll as planned; and ARC-7 data will be submitted later this year for presentation at a medical conference.</p>\n<p>Sprinklr (NYSE:CXM)9% HIGHER; shares are up following its NYSE debut Wednesday when it rose 10% after a weak start.</p>\n<p>Talos Energy Inc. (NYSE:TALO)6.2% LOWER; announced today an underwritten public offering of an aggregate of 5,000,000 shares of its common stock (the \"Offering\") by certain affiliates of Apollo Global Management and Riverstone Holdings LLC (the \"Selling Stockholders\"). Talos is not selling any shares of common stock in the Offering and will not receive any proceeds from any sale of shares by the Selling Stockholders.</p>\n<p>Steelcase (NYSE:SCS)5.2% HIGHER; reported Q1 EPS of ($0.24), $0.07 better than the analyst estimate of ($0.31). Revenue for the quarter came in at $566.6 million versus the consensus estimate of $554.8 million. Steelcase sees Q2 2021 EPS of $0.25-$0.30, versus the consensus of $0.22. Steelcase sees Q2 2021 revenue of $750-780 million, versus the consensus of $704 million.</p>\n<p>Lightening eMotors (NYSE:ZEV)4.2% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $15.00.</p>\n<p>KB Home (NYSE:KBH)3.8% LOWER; reported Q2 EPS of $1.50, $0.19 better than the analyst estimate of $1.31. Revenue for the quarter came in at $1.44 billion versus the consensus estimate of $1.5 billion.</p>\n<p>Intrepid Potash (NYSE:IPI)3.2% HIGHER; Increases Potash Price by $90; Trio® Price by $35</p>\n<p>Broadstone Net Lease, Inc. (NYSE:BNL)2.6% LOWER; announced that it has commenced an underwritten public offering of 10,000,000 shares of its common stock</p>\n<p>Beyond Meat Inc. (NASDAQ:BYND)1.5% LOWER; JPMorgan analyst Ken Goldman reiterated an Underweight rating on Beyond Meat Inc. (NASDAQ:BYND), saying based on their checks Dunkin’ recently discontinued the Beyond Sausage breakfast sandwich.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stocks making the biggest moves after hours: Beyond Meat, KB Home, Steelcase and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStocks making the biggest moves after hours: Beyond Meat, KB Home, Steelcase and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-24 07:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18597276><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Check out the companies making headlines after the bell:\nDHI Group, Inc. (NYSE:DHX)26.5% HIGHER; authorized a stock repurchase program that permits the additional purchase of up to $12 million of the ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18597276\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PRTG":"Portage Biotech Inc.","KBH":"KB Home","SCS":"Steelcase Inc.","BYND":"Beyond Meat, Inc.","CXM":"Sprinklr, Inc.","DHX":"戴斯控股"},"source_url":"https://www.streetinsider.com/dr/news.php?id=18597276","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1197804089","content_text":"Check out the companies making headlines after the bell:\nDHI Group, Inc. (NYSE:DHX)26.5% HIGHER; authorized a stock repurchase program that permits the additional purchase of up to $12 million of the Company's common stock, increasing the overall share buyback program to $20 million. In February 2021, the Board of Directors authorized the purchase of $8 million of its common stock and, under the plan, the Company has purchased approximately $1.3 million of its stock to date. With this additional authorization, the Company now has $18.7 million of buyback capacity.\nPortage Biotech Inc. (NASDAQ:PRTG)23.3% LOWER; commenced an underwritten public offering of its ordinary shares. In addition, Portage expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of the ordinary shares sold in connection with the offering. All of the ordinary shares in the offering are to be sold by Portage. This offering is subject to market conditions and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.\nArcus Biosciences, Inc. (NYSE:RCUS)19% HIGHER; announced that, at the first interim analysis of the three-arm randomized Phase 2 ARC-7 study, both arms with domvanalimab-based combinations showed encouraging clinical activity (measured by overall response rate; ORR) when given as an initial treatment (first-line) to people with metastatic, PD-L150% non-small cell lung cancer (NSCLC). The zimberelimab monotherapy arm showed activity similar to that of marketed anti-PD-1 antibodies studied by other companies in this setting. At the time of data cut off, no unexpected safety signals were observed; and the current safety profile for each arm of the study appears to be consistent with known immune checkpoint inhibitors in this setting. All three arms of the ARC-7 trial, and the ongoing ARC-10 Phase 3 registrational study, will continue to enroll as planned; and ARC-7 data will be submitted later this year for presentation at a medical conference.\nSprinklr (NYSE:CXM)9% HIGHER; shares are up following its NYSE debut Wednesday when it rose 10% after a weak start.\nTalos Energy Inc. (NYSE:TALO)6.2% LOWER; announced today an underwritten public offering of an aggregate of 5,000,000 shares of its common stock (the \"Offering\") by certain affiliates of Apollo Global Management and Riverstone Holdings LLC (the \"Selling Stockholders\"). Talos is not selling any shares of common stock in the Offering and will not receive any proceeds from any sale of shares by the Selling Stockholders.\nSteelcase (NYSE:SCS)5.2% HIGHER; reported Q1 EPS of ($0.24), $0.07 better than the analyst estimate of ($0.31). Revenue for the quarter came in at $566.6 million versus the consensus estimate of $554.8 million. Steelcase sees Q2 2021 EPS of $0.25-$0.30, versus the consensus of $0.22. Steelcase sees Q2 2021 revenue of $750-780 million, versus the consensus of $704 million.\nLightening eMotors (NYSE:ZEV)4.2% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $15.00.\nKB Home (NYSE:KBH)3.8% LOWER; reported Q2 EPS of $1.50, $0.19 better than the analyst estimate of $1.31. Revenue for the quarter came in at $1.44 billion versus the consensus estimate of $1.5 billion.\nIntrepid Potash (NYSE:IPI)3.2% HIGHER; Increases Potash Price by $90; Trio® Price by $35\nBroadstone Net Lease, Inc. (NYSE:BNL)2.6% LOWER; announced that it has commenced an underwritten public offering of 10,000,000 shares of its common stock\nBeyond Meat Inc. (NASDAQ:BYND)1.5% LOWER; JPMorgan analyst Ken Goldman reiterated an Underweight rating on Beyond Meat Inc. (NASDAQ:BYND), saying based on their checks Dunkin’ recently discontinued the Beyond Sausage breakfast sandwich.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":128507510,"gmtCreate":1624522205630,"gmtModify":1703839209945,"author":{"id":"3585350696038563","authorId":"3585350696038563","name":"JPTL","avatar":"https://static.tigerbbs.com/6f6dde4c2c1d83e8d80141b547948419","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3585350696038563","idStr":"3585350696038563"},"htmlText":"??","listText":"??","text":"??","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/128507510","repostId":1197804089,"repostType":4,"repost":{"id":"1197804089","pubTimestamp":1624491201,"share":"https://ttm.financial/m/news/1197804089?lang=&edition=fundamental","pubTime":"2021-06-24 07:33","market":"us","language":"en","title":"Stocks making the biggest moves after hours: Beyond Meat, KB Home, Steelcase and more","url":"https://stock-news.laohu8.com/highlight/detail?id=1197804089","media":"StreetInsider","summary":"Check out the companies making headlines after the bell:. DHI Group, Inc. 26.5% HIGHER; authorized a stock repurchase program that permits the additional purchase of up to $12 million of the Company's common stock, increasing the overall share buyback program to $20 million. In February 2021, the Board of Directors authorized the purchase of $8 million of its common stock and, under the plan, the Company has purchased approximately $1.3 million of its stock to date. With this additional authoriz","content":"<p><i>Check out the companies making headlines after the bell</i>:</p>\n<p>DHI Group, Inc. (NYSE:DHX)26.5% HIGHER; authorized a stock repurchase program that permits the additional purchase of up to $12 million of the Company's common stock, increasing the overall share buyback program to $20 million. In February 2021, the Board of Directors authorized the purchase of $8 million of its common stock and, under the plan, the Company has purchased approximately $1.3 million of its stock to date. With this additional authorization, the Company now has $18.7 million of buyback capacity.</p>\n<p>Portage Biotech Inc. (NASDAQ:PRTG)23.3% LOWER; commenced an underwritten public offering of its ordinary shares. In addition, Portage expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of the ordinary shares sold in connection with the offering. All of the ordinary shares in the offering are to be sold by Portage. This offering is subject to market conditions and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.</p>\n<p>Arcus Biosciences, Inc. (NYSE:RCUS)19% HIGHER; announced that, at the first interim analysis of the three-arm randomized Phase 2 ARC-7 study, both arms with domvanalimab-based combinations showed encouraging clinical activity (measured by overall response rate; ORR) when given as an initial treatment (first-line) to people with metastatic, PD-L150% non-small cell lung cancer (NSCLC). The zimberelimab monotherapy arm showed activity similar to that of marketed anti-PD-1 antibodies studied by other companies in this setting. At the time of data cut off, no unexpected safety signals were observed; and the current safety profile for each arm of the study appears to be consistent with known immune checkpoint inhibitors in this setting. All three arms of the ARC-7 trial, and the ongoing ARC-10 Phase 3 registrational study, will continue to enroll as planned; and ARC-7 data will be submitted later this year for presentation at a medical conference.</p>\n<p>Sprinklr (NYSE:CXM)9% HIGHER; shares are up following its NYSE debut Wednesday when it rose 10% after a weak start.</p>\n<p>Talos Energy Inc. (NYSE:TALO)6.2% LOWER; announced today an underwritten public offering of an aggregate of 5,000,000 shares of its common stock (the \"Offering\") by certain affiliates of Apollo Global Management and Riverstone Holdings LLC (the \"Selling Stockholders\"). Talos is not selling any shares of common stock in the Offering and will not receive any proceeds from any sale of shares by the Selling Stockholders.</p>\n<p>Steelcase (NYSE:SCS)5.2% HIGHER; reported Q1 EPS of ($0.24), $0.07 better than the analyst estimate of ($0.31). Revenue for the quarter came in at $566.6 million versus the consensus estimate of $554.8 million. Steelcase sees Q2 2021 EPS of $0.25-$0.30, versus the consensus of $0.22. Steelcase sees Q2 2021 revenue of $750-780 million, versus the consensus of $704 million.</p>\n<p>Lightening eMotors (NYSE:ZEV)4.2% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $15.00.</p>\n<p>KB Home (NYSE:KBH)3.8% LOWER; reported Q2 EPS of $1.50, $0.19 better than the analyst estimate of $1.31. Revenue for the quarter came in at $1.44 billion versus the consensus estimate of $1.5 billion.</p>\n<p>Intrepid Potash (NYSE:IPI)3.2% HIGHER; Increases Potash Price by $90; Trio® Price by $35</p>\n<p>Broadstone Net Lease, Inc. (NYSE:BNL)2.6% LOWER; announced that it has commenced an underwritten public offering of 10,000,000 shares of its common stock</p>\n<p>Beyond Meat Inc. (NASDAQ:BYND)1.5% LOWER; JPMorgan analyst Ken Goldman reiterated an Underweight rating on Beyond Meat Inc. (NASDAQ:BYND), saying based on their checks Dunkin’ recently discontinued the Beyond Sausage breakfast sandwich.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stocks making the biggest moves after hours: Beyond Meat, KB Home, Steelcase and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStocks making the biggest moves after hours: Beyond Meat, KB Home, Steelcase and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-24 07:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18597276><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Check out the companies making headlines after the bell:\nDHI Group, Inc. (NYSE:DHX)26.5% HIGHER; authorized a stock repurchase program that permits the additional purchase of up to $12 million of the ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18597276\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PRTG":"Portage Biotech Inc.","KBH":"KB Home","SCS":"Steelcase Inc.","BYND":"Beyond Meat, Inc.","CXM":"Sprinklr, Inc.","DHX":"戴斯控股"},"source_url":"https://www.streetinsider.com/dr/news.php?id=18597276","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1197804089","content_text":"Check out the companies making headlines after the bell:\nDHI Group, Inc. (NYSE:DHX)26.5% HIGHER; authorized a stock repurchase program that permits the additional purchase of up to $12 million of the Company's common stock, increasing the overall share buyback program to $20 million. In February 2021, the Board of Directors authorized the purchase of $8 million of its common stock and, under the plan, the Company has purchased approximately $1.3 million of its stock to date. With this additional authorization, the Company now has $18.7 million of buyback capacity.\nPortage Biotech Inc. (NASDAQ:PRTG)23.3% LOWER; commenced an underwritten public offering of its ordinary shares. In addition, Portage expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of the ordinary shares sold in connection with the offering. All of the ordinary shares in the offering are to be sold by Portage. This offering is subject to market conditions and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.\nArcus Biosciences, Inc. (NYSE:RCUS)19% HIGHER; announced that, at the first interim analysis of the three-arm randomized Phase 2 ARC-7 study, both arms with domvanalimab-based combinations showed encouraging clinical activity (measured by overall response rate; ORR) when given as an initial treatment (first-line) to people with metastatic, PD-L150% non-small cell lung cancer (NSCLC). The zimberelimab monotherapy arm showed activity similar to that of marketed anti-PD-1 antibodies studied by other companies in this setting. At the time of data cut off, no unexpected safety signals were observed; and the current safety profile for each arm of the study appears to be consistent with known immune checkpoint inhibitors in this setting. All three arms of the ARC-7 trial, and the ongoing ARC-10 Phase 3 registrational study, will continue to enroll as planned; and ARC-7 data will be submitted later this year for presentation at a medical conference.\nSprinklr (NYSE:CXM)9% HIGHER; shares are up following its NYSE debut Wednesday when it rose 10% after a weak start.\nTalos Energy Inc. (NYSE:TALO)6.2% LOWER; announced today an underwritten public offering of an aggregate of 5,000,000 shares of its common stock (the \"Offering\") by certain affiliates of Apollo Global Management and Riverstone Holdings LLC (the \"Selling Stockholders\"). Talos is not selling any shares of common stock in the Offering and will not receive any proceeds from any sale of shares by the Selling Stockholders.\nSteelcase (NYSE:SCS)5.2% HIGHER; reported Q1 EPS of ($0.24), $0.07 better than the analyst estimate of ($0.31). Revenue for the quarter came in at $566.6 million versus the consensus estimate of $554.8 million. Steelcase sees Q2 2021 EPS of $0.25-$0.30, versus the consensus of $0.22. Steelcase sees Q2 2021 revenue of $750-780 million, versus the consensus of $704 million.\nLightening eMotors (NYSE:ZEV)4.2% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $15.00.\nKB Home (NYSE:KBH)3.8% LOWER; reported Q2 EPS of $1.50, $0.19 better than the analyst estimate of $1.31. Revenue for the quarter came in at $1.44 billion versus the consensus estimate of $1.5 billion.\nIntrepid Potash (NYSE:IPI)3.2% HIGHER; Increases Potash Price by $90; Trio® Price by $35\nBroadstone Net Lease, Inc. (NYSE:BNL)2.6% LOWER; announced that it has commenced an underwritten public offering of 10,000,000 shares of its common stock\nBeyond Meat Inc. (NASDAQ:BYND)1.5% LOWER; JPMorgan analyst Ken Goldman reiterated an Underweight rating on Beyond Meat Inc. (NASDAQ:BYND), saying based on their checks Dunkin’ recently discontinued the Beyond Sausage breakfast sandwich.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":128887717,"gmtCreate":1624510304539,"gmtModify":1703838840570,"author":{"id":"3581587218422611","authorId":"3581587218422611","name":"lgperry","avatar":"https://static.tigerbbs.com/957dde71740ea5768c42b7133e50af7a","vip":1,"crmLevel":2,"crmLevelSwitch":0,"authorIdStr":"3581587218422611","idStr":"3581587218422611"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/128887717","repostId":1197804089,"repostType":4,"repost":{"id":"1197804089","pubTimestamp":1624491201,"share":"https://ttm.financial/m/news/1197804089?lang=&edition=fundamental","pubTime":"2021-06-24 07:33","market":"us","language":"en","title":"Stocks making the biggest moves after hours: Beyond Meat, KB Home, Steelcase and more","url":"https://stock-news.laohu8.com/highlight/detail?id=1197804089","media":"StreetInsider","summary":"Check out the companies making headlines after the bell:. DHI Group, Inc. 26.5% HIGHER; authorized a stock repurchase program that permits the additional purchase of up to $12 million of the Company's common stock, increasing the overall share buyback program to $20 million. In February 2021, the Board of Directors authorized the purchase of $8 million of its common stock and, under the plan, the Company has purchased approximately $1.3 million of its stock to date. With this additional authoriz","content":"<p><i>Check out the companies making headlines after the bell</i>:</p>\n<p>DHI Group, Inc. (NYSE:DHX)26.5% HIGHER; authorized a stock repurchase program that permits the additional purchase of up to $12 million of the Company's common stock, increasing the overall share buyback program to $20 million. In February 2021, the Board of Directors authorized the purchase of $8 million of its common stock and, under the plan, the Company has purchased approximately $1.3 million of its stock to date. With this additional authorization, the Company now has $18.7 million of buyback capacity.</p>\n<p>Portage Biotech Inc. (NASDAQ:PRTG)23.3% LOWER; commenced an underwritten public offering of its ordinary shares. In addition, Portage expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of the ordinary shares sold in connection with the offering. All of the ordinary shares in the offering are to be sold by Portage. This offering is subject to market conditions and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.</p>\n<p>Arcus Biosciences, Inc. (NYSE:RCUS)19% HIGHER; announced that, at the first interim analysis of the three-arm randomized Phase 2 ARC-7 study, both arms with domvanalimab-based combinations showed encouraging clinical activity (measured by overall response rate; ORR) when given as an initial treatment (first-line) to people with metastatic, PD-L150% non-small cell lung cancer (NSCLC). The zimberelimab monotherapy arm showed activity similar to that of marketed anti-PD-1 antibodies studied by other companies in this setting. At the time of data cut off, no unexpected safety signals were observed; and the current safety profile for each arm of the study appears to be consistent with known immune checkpoint inhibitors in this setting. All three arms of the ARC-7 trial, and the ongoing ARC-10 Phase 3 registrational study, will continue to enroll as planned; and ARC-7 data will be submitted later this year for presentation at a medical conference.</p>\n<p>Sprinklr (NYSE:CXM)9% HIGHER; shares are up following its NYSE debut Wednesday when it rose 10% after a weak start.</p>\n<p>Talos Energy Inc. (NYSE:TALO)6.2% LOWER; announced today an underwritten public offering of an aggregate of 5,000,000 shares of its common stock (the \"Offering\") by certain affiliates of Apollo Global Management and Riverstone Holdings LLC (the \"Selling Stockholders\"). Talos is not selling any shares of common stock in the Offering and will not receive any proceeds from any sale of shares by the Selling Stockholders.</p>\n<p>Steelcase (NYSE:SCS)5.2% HIGHER; reported Q1 EPS of ($0.24), $0.07 better than the analyst estimate of ($0.31). Revenue for the quarter came in at $566.6 million versus the consensus estimate of $554.8 million. Steelcase sees Q2 2021 EPS of $0.25-$0.30, versus the consensus of $0.22. Steelcase sees Q2 2021 revenue of $750-780 million, versus the consensus of $704 million.</p>\n<p>Lightening eMotors (NYSE:ZEV)4.2% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $15.00.</p>\n<p>KB Home (NYSE:KBH)3.8% LOWER; reported Q2 EPS of $1.50, $0.19 better than the analyst estimate of $1.31. Revenue for the quarter came in at $1.44 billion versus the consensus estimate of $1.5 billion.</p>\n<p>Intrepid Potash (NYSE:IPI)3.2% HIGHER; Increases Potash Price by $90; Trio® Price by $35</p>\n<p>Broadstone Net Lease, Inc. (NYSE:BNL)2.6% LOWER; announced that it has commenced an underwritten public offering of 10,000,000 shares of its common stock</p>\n<p>Beyond Meat Inc. (NASDAQ:BYND)1.5% LOWER; JPMorgan analyst Ken Goldman reiterated an Underweight rating on Beyond Meat Inc. (NASDAQ:BYND), saying based on their checks Dunkin’ recently discontinued the Beyond Sausage breakfast sandwich.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stocks making the biggest moves after hours: Beyond Meat, KB Home, Steelcase and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStocks making the biggest moves after hours: Beyond Meat, KB Home, Steelcase and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-24 07:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18597276><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Check out the companies making headlines after the bell:\nDHI Group, Inc. (NYSE:DHX)26.5% HIGHER; authorized a stock repurchase program that permits the additional purchase of up to $12 million of the ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18597276\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PRTG":"Portage Biotech Inc.","KBH":"KB Home","SCS":"Steelcase Inc.","BYND":"Beyond Meat, Inc.","CXM":"Sprinklr, Inc.","DHX":"戴斯控股"},"source_url":"https://www.streetinsider.com/dr/news.php?id=18597276","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1197804089","content_text":"Check out the companies making headlines after the bell:\nDHI Group, Inc. (NYSE:DHX)26.5% HIGHER; authorized a stock repurchase program that permits the additional purchase of up to $12 million of the Company's common stock, increasing the overall share buyback program to $20 million. In February 2021, the Board of Directors authorized the purchase of $8 million of its common stock and, under the plan, the Company has purchased approximately $1.3 million of its stock to date. With this additional authorization, the Company now has $18.7 million of buyback capacity.\nPortage Biotech Inc. (NASDAQ:PRTG)23.3% LOWER; commenced an underwritten public offering of its ordinary shares. In addition, Portage expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of the ordinary shares sold in connection with the offering. All of the ordinary shares in the offering are to be sold by Portage. This offering is subject to market conditions and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.\nArcus Biosciences, Inc. (NYSE:RCUS)19% HIGHER; announced that, at the first interim analysis of the three-arm randomized Phase 2 ARC-7 study, both arms with domvanalimab-based combinations showed encouraging clinical activity (measured by overall response rate; ORR) when given as an initial treatment (first-line) to people with metastatic, PD-L150% non-small cell lung cancer (NSCLC). The zimberelimab monotherapy arm showed activity similar to that of marketed anti-PD-1 antibodies studied by other companies in this setting. At the time of data cut off, no unexpected safety signals were observed; and the current safety profile for each arm of the study appears to be consistent with known immune checkpoint inhibitors in this setting. All three arms of the ARC-7 trial, and the ongoing ARC-10 Phase 3 registrational study, will continue to enroll as planned; and ARC-7 data will be submitted later this year for presentation at a medical conference.\nSprinklr (NYSE:CXM)9% HIGHER; shares are up following its NYSE debut Wednesday when it rose 10% after a weak start.\nTalos Energy Inc. (NYSE:TALO)6.2% LOWER; announced today an underwritten public offering of an aggregate of 5,000,000 shares of its common stock (the \"Offering\") by certain affiliates of Apollo Global Management and Riverstone Holdings LLC (the \"Selling Stockholders\"). Talos is not selling any shares of common stock in the Offering and will not receive any proceeds from any sale of shares by the Selling Stockholders.\nSteelcase (NYSE:SCS)5.2% HIGHER; reported Q1 EPS of ($0.24), $0.07 better than the analyst estimate of ($0.31). Revenue for the quarter came in at $566.6 million versus the consensus estimate of $554.8 million. Steelcase sees Q2 2021 EPS of $0.25-$0.30, versus the consensus of $0.22. Steelcase sees Q2 2021 revenue of $750-780 million, versus the consensus of $704 million.\nLightening eMotors (NYSE:ZEV)4.2% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $15.00.\nKB Home (NYSE:KBH)3.8% LOWER; reported Q2 EPS of $1.50, $0.19 better than the analyst estimate of $1.31. Revenue for the quarter came in at $1.44 billion versus the consensus estimate of $1.5 billion.\nIntrepid Potash (NYSE:IPI)3.2% HIGHER; Increases Potash Price by $90; Trio® Price by $35\nBroadstone Net Lease, Inc. (NYSE:BNL)2.6% LOWER; announced that it has commenced an underwritten public offering of 10,000,000 shares of its common stock\nBeyond Meat Inc. (NASDAQ:BYND)1.5% LOWER; JPMorgan analyst Ken Goldman reiterated an Underweight rating on Beyond Meat Inc. (NASDAQ:BYND), saying based on their checks Dunkin’ recently discontinued the Beyond Sausage breakfast sandwich.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":128179797,"gmtCreate":1624508303719,"gmtModify":1703838753493,"author":{"id":"3583189999419590","authorId":"3583189999419590","name":"Jtrfed","avatar":"https://static.tigerbbs.com/e902a73b1f6967436d3841166a63afe7","vip":1,"crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"3583189999419590","idStr":"3583189999419590"},"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/128179797","repostId":1197804089,"repostType":4,"repost":{"id":"1197804089","pubTimestamp":1624491201,"share":"https://ttm.financial/m/news/1197804089?lang=&edition=fundamental","pubTime":"2021-06-24 07:33","market":"us","language":"en","title":"Stocks making the biggest moves after hours: Beyond Meat, KB Home, Steelcase and more","url":"https://stock-news.laohu8.com/highlight/detail?id=1197804089","media":"StreetInsider","summary":"Check out the companies making headlines after the bell:. DHI Group, Inc. 26.5% HIGHER; authorized a stock repurchase program that permits the additional purchase of up to $12 million of the Company's common stock, increasing the overall share buyback program to $20 million. In February 2021, the Board of Directors authorized the purchase of $8 million of its common stock and, under the plan, the Company has purchased approximately $1.3 million of its stock to date. With this additional authoriz","content":"<p><i>Check out the companies making headlines after the bell</i>:</p>\n<p>DHI Group, Inc. (NYSE:DHX)26.5% HIGHER; authorized a stock repurchase program that permits the additional purchase of up to $12 million of the Company's common stock, increasing the overall share buyback program to $20 million. In February 2021, the Board of Directors authorized the purchase of $8 million of its common stock and, under the plan, the Company has purchased approximately $1.3 million of its stock to date. With this additional authorization, the Company now has $18.7 million of buyback capacity.</p>\n<p>Portage Biotech Inc. (NASDAQ:PRTG)23.3% LOWER; commenced an underwritten public offering of its ordinary shares. In addition, Portage expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of the ordinary shares sold in connection with the offering. All of the ordinary shares in the offering are to be sold by Portage. This offering is subject to market conditions and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.</p>\n<p>Arcus Biosciences, Inc. (NYSE:RCUS)19% HIGHER; announced that, at the first interim analysis of the three-arm randomized Phase 2 ARC-7 study, both arms with domvanalimab-based combinations showed encouraging clinical activity (measured by overall response rate; ORR) when given as an initial treatment (first-line) to people with metastatic, PD-L150% non-small cell lung cancer (NSCLC). The zimberelimab monotherapy arm showed activity similar to that of marketed anti-PD-1 antibodies studied by other companies in this setting. At the time of data cut off, no unexpected safety signals were observed; and the current safety profile for each arm of the study appears to be consistent with known immune checkpoint inhibitors in this setting. All three arms of the ARC-7 trial, and the ongoing ARC-10 Phase 3 registrational study, will continue to enroll as planned; and ARC-7 data will be submitted later this year for presentation at a medical conference.</p>\n<p>Sprinklr (NYSE:CXM)9% HIGHER; shares are up following its NYSE debut Wednesday when it rose 10% after a weak start.</p>\n<p>Talos Energy Inc. (NYSE:TALO)6.2% LOWER; announced today an underwritten public offering of an aggregate of 5,000,000 shares of its common stock (the \"Offering\") by certain affiliates of Apollo Global Management and Riverstone Holdings LLC (the \"Selling Stockholders\"). Talos is not selling any shares of common stock in the Offering and will not receive any proceeds from any sale of shares by the Selling Stockholders.</p>\n<p>Steelcase (NYSE:SCS)5.2% HIGHER; reported Q1 EPS of ($0.24), $0.07 better than the analyst estimate of ($0.31). Revenue for the quarter came in at $566.6 million versus the consensus estimate of $554.8 million. Steelcase sees Q2 2021 EPS of $0.25-$0.30, versus the consensus of $0.22. Steelcase sees Q2 2021 revenue of $750-780 million, versus the consensus of $704 million.</p>\n<p>Lightening eMotors (NYSE:ZEV)4.2% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $15.00.</p>\n<p>KB Home (NYSE:KBH)3.8% LOWER; reported Q2 EPS of $1.50, $0.19 better than the analyst estimate of $1.31. Revenue for the quarter came in at $1.44 billion versus the consensus estimate of $1.5 billion.</p>\n<p>Intrepid Potash (NYSE:IPI)3.2% HIGHER; Increases Potash Price by $90; Trio® Price by $35</p>\n<p>Broadstone Net Lease, Inc. (NYSE:BNL)2.6% LOWER; announced that it has commenced an underwritten public offering of 10,000,000 shares of its common stock</p>\n<p>Beyond Meat Inc. (NASDAQ:BYND)1.5% LOWER; JPMorgan analyst Ken Goldman reiterated an Underweight rating on Beyond Meat Inc. (NASDAQ:BYND), saying based on their checks Dunkin’ recently discontinued the Beyond Sausage breakfast sandwich.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stocks making the biggest moves after hours: Beyond Meat, KB Home, Steelcase and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStocks making the biggest moves after hours: Beyond Meat, KB Home, Steelcase and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-24 07:33 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18597276><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Check out the companies making headlines after the bell:\nDHI Group, Inc. (NYSE:DHX)26.5% HIGHER; authorized a stock repurchase program that permits the additional purchase of up to $12 million of the ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18597276\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PRTG":"Portage Biotech Inc.","KBH":"KB Home","SCS":"Steelcase Inc.","BYND":"Beyond Meat, Inc.","CXM":"Sprinklr, Inc.","DHX":"戴斯控股"},"source_url":"https://www.streetinsider.com/dr/news.php?id=18597276","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1197804089","content_text":"Check out the companies making headlines after the bell:\nDHI Group, Inc. (NYSE:DHX)26.5% HIGHER; authorized a stock repurchase program that permits the additional purchase of up to $12 million of the Company's common stock, increasing the overall share buyback program to $20 million. In February 2021, the Board of Directors authorized the purchase of $8 million of its common stock and, under the plan, the Company has purchased approximately $1.3 million of its stock to date. With this additional authorization, the Company now has $18.7 million of buyback capacity.\nPortage Biotech Inc. (NASDAQ:PRTG)23.3% LOWER; commenced an underwritten public offering of its ordinary shares. In addition, Portage expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the number of the ordinary shares sold in connection with the offering. All of the ordinary shares in the offering are to be sold by Portage. This offering is subject to market conditions and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.\nArcus Biosciences, Inc. (NYSE:RCUS)19% HIGHER; announced that, at the first interim analysis of the three-arm randomized Phase 2 ARC-7 study, both arms with domvanalimab-based combinations showed encouraging clinical activity (measured by overall response rate; ORR) when given as an initial treatment (first-line) to people with metastatic, PD-L150% non-small cell lung cancer (NSCLC). The zimberelimab monotherapy arm showed activity similar to that of marketed anti-PD-1 antibodies studied by other companies in this setting. At the time of data cut off, no unexpected safety signals were observed; and the current safety profile for each arm of the study appears to be consistent with known immune checkpoint inhibitors in this setting. All three arms of the ARC-7 trial, and the ongoing ARC-10 Phase 3 registrational study, will continue to enroll as planned; and ARC-7 data will be submitted later this year for presentation at a medical conference.\nSprinklr (NYSE:CXM)9% HIGHER; shares are up following its NYSE debut Wednesday when it rose 10% after a weak start.\nTalos Energy Inc. (NYSE:TALO)6.2% LOWER; announced today an underwritten public offering of an aggregate of 5,000,000 shares of its common stock (the \"Offering\") by certain affiliates of Apollo Global Management and Riverstone Holdings LLC (the \"Selling Stockholders\"). Talos is not selling any shares of common stock in the Offering and will not receive any proceeds from any sale of shares by the Selling Stockholders.\nSteelcase (NYSE:SCS)5.2% HIGHER; reported Q1 EPS of ($0.24), $0.07 better than the analyst estimate of ($0.31). Revenue for the quarter came in at $566.6 million versus the consensus estimate of $554.8 million. Steelcase sees Q2 2021 EPS of $0.25-$0.30, versus the consensus of $0.22. Steelcase sees Q2 2021 revenue of $750-780 million, versus the consensus of $704 million.\nLightening eMotors (NYSE:ZEV)4.2% HIGHER; Oppenheimer initiates coverage with an Outperform rating and a price target of $15.00.\nKB Home (NYSE:KBH)3.8% LOWER; reported Q2 EPS of $1.50, $0.19 better than the analyst estimate of $1.31. Revenue for the quarter came in at $1.44 billion versus the consensus estimate of $1.5 billion.\nIntrepid Potash (NYSE:IPI)3.2% HIGHER; Increases Potash Price by $90; Trio® Price by $35\nBroadstone Net Lease, Inc. (NYSE:BNL)2.6% LOWER; announced that it has commenced an underwritten public offering of 10,000,000 shares of its common stock\nBeyond Meat Inc. (NASDAQ:BYND)1.5% LOWER; JPMorgan analyst Ken Goldman reiterated an Underweight rating on Beyond Meat Inc. (NASDAQ:BYND), saying based on their checks Dunkin’ recently discontinued the Beyond Sausage breakfast sandwich.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":223,"commentSize":68,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1197804089"}